What is the recommended dosage of praziquantel (PZQ) for pediatric patients with paragonimiasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Praziquantel Dosing for Pediatric Paragonimiasis

For pediatric paragonimiasis, administer praziquantel 75 mg/kg/day divided into three doses (25 mg/kg three times daily) for 2 consecutive days, given orally with food.

Standard Dosing Regimen

  • The recommended dose is 75 mg/kg/day divided into three doses (25 mg/kg three times daily) for 2 consecutive days 1, 2, 3, 4
  • All doses should be administered with food to optimize absorption 5
  • This regimen applies to all pediatric age groups, including preschool-aged children (2-5 years) and school-aged children (6-15 years) 6

Evidence Supporting This Dosing

  • Clinical trials in paragonimiasis patients demonstrated that 75 mg/kg/day for 2 days achieved cure rates of 85.7-100%, significantly higher than lower doses 1, 3
  • The 75 mg/kg/day regimen showed 90.8-96.8% reduction in egg counts with a 97.6% cure rate, compared to only 71.1% cure rate with 45 mg/kg/day 1
  • A study of 52 patients treated with 3 × 25 mg/kg for 2 consecutive days achieved 85.7% cure rate, with overall cure rate of 95.2% after retreatment of failures 3
  • Seven of eight patients treated with 75 mg/kg/day for 2 days became ova-negative by day 90-120 post-treatment 4

Treatment Failures and Retreatment

  • If sputum or stool specimens remain ova-positive at 3-4 months follow-up, retreat with the same regimen (75 mg/kg/day for 2-3 consecutive days) 3, 4
  • One patient who received the total dose of 150 mg/kg spread over 4 days (rather than 2 consecutive days) remained ova-positive, suggesting that dose concentration over consecutive days is critical 4

Safety Profile

  • Praziquantel is well-tolerated in pediatric patients with mild, transient side effects 3, 6
  • Common adverse effects include headache, dizziness, nausea, diarrhea, stomach ache, and vomiting occurring within 3 hours post-treatment 3, 6, 4
  • Urticaria may occur, possibly from antigen release from drug-damaged parasites 4
  • No serious adverse events or abnormal hematological, biochemical, or urinalysis findings have been reported in pediatric paragonimiasis treatment 3

Critical Pitfalls to Avoid

  • Never use praziquantel for suspected tapeworm (T. solium) infection without neuroimaging first, as it can precipitate cerebral edema, seizures, or death if neurocysticercosis is present 7
  • Avoid splitting the total dose over more than 2-3 consecutive days, as this reduces efficacy 4
  • Do not use dexamethasone concurrently if corticosteroids are needed, as it significantly reduces praziquantel serum levels; use prednisolone instead 5, 7
  • Monitor antiepileptic drug levels (phenytoin, carbamazepine) during treatment, as levels may decrease 5

Follow-up Monitoring

  • Perform sputum and stool examinations for ova at 3-4 months post-treatment to assess cure 3, 4
  • Chest X-ray can document resolution of abnormal shadows 3
  • Serum antibody testing (immunoelectrophoresis) showing disappearance of precipitating bands provides additional confirmation of cure 3

References

Research

Clinical field trials of praziquantel in pulmonary paragonimiasis due to Paragonimus uterobilateralis in endemic populations of the Igwun Basin, Nigeria.

Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ), 1989

Research

[Paragonimiasis westermani caused by ingestion of Chinese freshwater crabs].

Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2003

Research

Clinical Evaluation Of Praziquantel(Embay 8440; Biltricide(R)) In The Treatment Of Paragonimus Westermani.

Kisaengch'unghak chapchi. The Korean journal of parasitology, 1981

Guideline

Praziquantel Treatment Guidelines for Schistosomiasis and Fluke Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Neurocysticercosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended dose of praziquantel (PZQ) for pediatric patients with paragonimiasis, by age group?
What is the recommended treatment and dosage of praziquantel (PZQ) for paragonimiasis in pediatric patients, including children over 4 years old and infants under 4 years old?
What is the recommended treatment for a patient with paragonimiasis presenting with abdominal enlargement?
What are the potential causes and recommended management for a patient presenting with cough, severe lower back pain, and right arm weakness 9 days after taking praziquantel (an antiparasitic medication)?
What is the recommended treatment for a patient infected with Paragonimus westermanii, considering their medical history and potential respiratory complications?
What is the recommended starting dosage of venlafaxine (Effexor) for a patient with post-traumatic stress disorder (PTSD) and brief psychotic episodes?
What is the recommended approach to intravenous fluid management for preventing hypotension in patients undergoing spinal anesthesia?
What is the primary physiological difference between Cushing's disease and Cushing's syndrome (Cushing's syndrome refers to excess cortisol in the body, while Cushing's disease is a specific form caused by a pituitary adenoma)?
What is the recommended treatment for a sexually active individual diagnosed with Chancroid, characterized by painful genital ulcers?
What is the most appropriate next step for a vitally stable patient with mild right upper quadrant abdominal pain after a recent road traffic accident (RTA)?
What is the management approach for a patient with increased troponin levels and pulmonary congestion, considering potential cardiac involvement and possible underlying conditions such as heart disease, hypertension, diabetes, or renal disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.